Tissellis BioSciences

Real tissue, regenerated

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Boston, MA 02125, USA
  • Currency USD
  • Founded April 2023
  • Employees 3
  • Incorporation Type C-corp
  • Website tissellisbio.com

Company Summary

We are developing a novel treatment for the repair of cartilage defects. Using our patented manufacturing technique, we bioprint microspheres of living cartilage tissues. These tissues integrate into the surrounding tissues, resulting in complete repair of the defect with mechanical and histologic properties comparable to native cartilage. Our product will deliver a more complete, sustainable recovery in a shorter time than existing treatments.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free